A randomized, double-blind, multicenter phase III study evaluating paclitaxel with and without RAD001 in patients with gastric cancer who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
暂无分享,去创建一个
M. Egger | A. Vogel | S. Al-Batran | J. Siveke | S. Probst | D. Pink | T. Goetze | H. Hebart | M. Stahl | J. Riera-Knorrenschild | T. Dechow | F. Kullmann | S. Lorenzen | S. Hegewisch‐Becker | P. Thuss-Patience | C. Pauligk | J. Seraphin | N. Homann | H. Kopp | K. Luley